Diagnos Stock Price on December 20, 2024
| ADK Stock | CAD 0.37 0.02 5.71% |
Below is the normalized historical share price chart for Diagnos extending back to June 28, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Diagnos stands at 0.37, as last reported on the 31st of January, with the highest price reaching 0.37 and the lowest price hitting 0.36 during the day.
If you're considering investing in Diagnos Stock, it is important to understand the factors that can impact its price. Diagnos appears to be out of control, given 3 months investment horizon. Diagnos secures Sharpe Ratio (or Efficiency) of 0.0816, which denotes the company had a 0.0816 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Diagnos, which you can use to evaluate the volatility of the firm. Please utilize Diagnos' Semi Deviation of 2.65, downside deviation of 4.08, and Mean Deviation of 2.64 to check if our risk estimates are consistent with your expectations.
At this time, Diagnos' Common Stock Shares Outstanding is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 208.5 K in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 725.2 K in 2025. . At this time, Diagnos' Price To Sales Ratio is fairly stable compared to the past year. Price Sales Ratio is likely to climb to 154.72 in 2025, whereas Price Earnings Ratio is likely to drop (6.06) in 2025. Diagnos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.3226 | 50 Day MA 0.315 | Beta (0.46) |
Diagnos |
Sharpe Ratio = 0.0816
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ADK | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.68 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Diagnos is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Diagnos by adding it to a well-diversified portfolio.
Price Book 54.6059 | Enterprise Value Ebitda (6.16) | Price Sales 212.0417 | Shares Float 76.7 M | Wall Street Target Price 1.5 |
Diagnos Valuation on December 20, 2024
It is possible to determine the worth of Diagnos on a given historical date. On December 20, 2024 Diagnos was worth 0.32 at the beginning of the trading date compared to the closed value of 0.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Diagnos stock. Still, in general, we apply an absolute valuation method to find Diagnos' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Diagnos where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Diagnos' related companies.
| Open | High | Low | Close | Volume | |
| 0.33 | 0.33 | 0.32 | 0.32 | 100,100 | |
12/20/2024 | 0.32 | 0.32 | 0.31 | 0.31 | 116,500 |
| 0.31 | 0.31 | 0.30 | 0.31 | 164,500 |
| Backtest Diagnos | | | Diagnos History | | | Diagnos Valuation | Previous | Next |
Diagnos Trading Date Momentum on December 20, 2024
| On December 23 2024 Diagnos was traded for 0.31 at the closing time. The highest daily price throughout the period was 0.31 and the lowest price was 0.30 . The daily volume was 164.5 K. The net trading volume on 12/23/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Diagnos Fundamentals Correlations and Trends
By evaluating Diagnos' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Diagnos' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Diagnos financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Diagnos Stock history
Diagnos investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Diagnos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Diagnos will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Diagnos stock prices may prove useful in developing a viable investing in Diagnos
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 83.7 M | 87.9 M | |
| Net Loss | -2.3 M | -2.5 M |
Diagnos Stock Technical Analysis
Diagnos technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Diagnos Period Price Range
Low | January 31, 2025
| High |
0.00 | 0.00 |
Diagnos cannot be verified against its exchange. Please verify the symbol is currently traded on TSX Venture Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Diagnos January 31, 2025 Market Strength
Market strength indicators help investors to evaluate how Diagnos stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Diagnos shares will generate the highest return on investment. By undertsting and applying Diagnos stock market strength indicators, traders can identify Diagnos entry and exit signals to maximize returns
Diagnos Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Diagnos' price direction in advance. Along with the technical and fundamental analysis of Diagnos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Diagnos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.052 | |||
| Jensen Alpha | 0.2299 | |||
| Total Risk Alpha | (0.21) | |||
| Sortino Ratio | 0.0225 | |||
| Treynor Ratio | (0.34) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Diagnos Stock Analysis
When running Diagnos' price analysis, check to measure Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnos is operating at the current time. Most of Diagnos' value examination focuses on studying past and present price action to predict the probability of Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnos' price. Additionally, you may evaluate how the addition of Diagnos to your portfolios can decrease your overall portfolio volatility.